Cargando…
A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy
The Electro-Neuro-Adaptive-Regulator (ENAR) device is a hand-held electrotherapy which is applied using energetic medicine principles and aspects of acupuncture theory. The aim of this paper is to report the findings of a postmarket survey of persons who have used the ENAR device. The conditions for...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068052/ https://www.ncbi.nlm.nih.gov/pubmed/24999365 http://dx.doi.org/10.1155/2014/341256 |
_version_ | 1782322375316996096 |
---|---|
author | Bonello, Rod P. Cohen, Marc Reece, John Aggarwal, Arun Rigney, Curtis |
author_facet | Bonello, Rod P. Cohen, Marc Reece, John Aggarwal, Arun Rigney, Curtis |
author_sort | Bonello, Rod P. |
collection | PubMed |
description | The Electro-Neuro-Adaptive-Regulator (ENAR) device is a hand-held electrotherapy which is applied using energetic medicine principles and aspects of acupuncture theory. The aim of this paper is to report the findings of a postmarket survey of persons who have used the ENAR device. The conditions for which the therapy was used and its perceived effectiveness are discussed. A web-based survey of Australian recipients of ENAR therapy was completed by 481 respondents. Most (76%) used ENAR exclusively for pain relief for musculoskeletal disorders, especially back, shoulder, and neck pain; 8% used ENAR exclusively for nonmusculoskeletal disorders; while 16% used ENAR for both. Respondents reported a mean reduction in pain of 70% (t(423) = 38.73, P < .001) and functional improvement of 62% (t(423) = 10.45, P < .001) using 11-point numerical rating scales. Following ENAR treatment, medication reduction was reported by 91% of respondents. Most respondents reported high satisfaction following ENAR therapy, with between 15 and 20% achieving complete pain relief. The self-delivery of ENAR may, in part, account for the high level of satisfaction. |
format | Online Article Text |
id | pubmed-4068052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-40680522014-07-06 A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy Bonello, Rod P. Cohen, Marc Reece, John Aggarwal, Arun Rigney, Curtis Evid Based Complement Alternat Med Research Article The Electro-Neuro-Adaptive-Regulator (ENAR) device is a hand-held electrotherapy which is applied using energetic medicine principles and aspects of acupuncture theory. The aim of this paper is to report the findings of a postmarket survey of persons who have used the ENAR device. The conditions for which the therapy was used and its perceived effectiveness are discussed. A web-based survey of Australian recipients of ENAR therapy was completed by 481 respondents. Most (76%) used ENAR exclusively for pain relief for musculoskeletal disorders, especially back, shoulder, and neck pain; 8% used ENAR exclusively for nonmusculoskeletal disorders; while 16% used ENAR for both. Respondents reported a mean reduction in pain of 70% (t(423) = 38.73, P < .001) and functional improvement of 62% (t(423) = 10.45, P < .001) using 11-point numerical rating scales. Following ENAR treatment, medication reduction was reported by 91% of respondents. Most respondents reported high satisfaction following ENAR therapy, with between 15 and 20% achieving complete pain relief. The self-delivery of ENAR may, in part, account for the high level of satisfaction. Hindawi Publishing Corporation 2014 2014-06-05 /pmc/articles/PMC4068052/ /pubmed/24999365 http://dx.doi.org/10.1155/2014/341256 Text en Copyright © 2014 Rod P. Bonello et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bonello, Rod P. Cohen, Marc Reece, John Aggarwal, Arun Rigney, Curtis A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy |
title | A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy |
title_full | A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy |
title_fullStr | A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy |
title_full_unstemmed | A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy |
title_short | A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy |
title_sort | postmarket surveillance study on electro-neuro-adaptive-regulator therapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068052/ https://www.ncbi.nlm.nih.gov/pubmed/24999365 http://dx.doi.org/10.1155/2014/341256 |
work_keys_str_mv | AT bonellorodp apostmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy AT cohenmarc apostmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy AT reecejohn apostmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy AT aggarwalarun apostmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy AT rigneycurtis apostmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy AT bonellorodp postmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy AT cohenmarc postmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy AT reecejohn postmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy AT aggarwalarun postmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy AT rigneycurtis postmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy |